Cencora, Inc. last reported quarterly results on Oct 21, 2026, for Q4 FY2026 (the quarter ended Sep 30, 2026). It usually reports 21–36 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 3, 2027.
Results for Q1 FY2027, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 4, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 21–36 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 21, 2026
21 days after quarter end
|
Q4 FY2026
ended Sep 30, 2026
|
—
|
—
|
—
|
|
Aug 5, 2026
36 days after quarter end
|
Q3 FY2026
ended Jun 30, 2026
|
84,755
+5.1%
|
764
+11.1%
|
3.94
+11.9%
|
|
May 6, 2026
36 days after quarter end
|
Q2 FY2026
ended Mar 31, 2026
|
78,356
+3.8%
|
1,641
+128.6%
|
8.40
+128.3%
|
|
Feb 4, 2026
35 days after quarter end
|
Q1 FY2026
ended Dec 31, 2025
|
85,932
+5.5%
|
560
+14.5%
|
2.87
+14.8%
|
|
Nov 5, 2025
36 days after quarter end
|
Q4 FY2025
ended Sep 30, 2025
|
83,729
+5.9%
|
-340
-10144.5%
|
-1.74
-10285.7%
|
|
Aug 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Jun 30, 2025
|
80,664
+8.7%
|
687
+42.2%
|
3.52
+45.5%
|
|
May 7, 2025
37 days after quarter end
|
Q2 FY2025
ended Mar 31, 2025
|
75,454
+10.3%
|
718
+70.6%
|
3.68
+76.1%
|
|
Feb 5, 2025
36 days after quarter end
|
Q1 FY2025
ended Dec 31, 2024
|
81,487
+12.8%
|
489
-18.8%
|
2.50
-16.1%
|
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- COR (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Conshohocken, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1140859
- Former names
- AMERISOURCEBERGEN CORP (until Aug 15, 2023); AMERISOURCE BERGEN CORP (until Oct 9, 2001)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.